← Back to Search

Procedure

Retrograde Urethrograms for Urethral Stricture

N/A
Recruiting
Research Sponsored by Northern Ontario School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up intra-procedure (during the urethroplasty)
Awards & highlights

Study Summary

This trial will compare the accuracy of two techniques for diagnosing urethral stricture disease in patients. Results will help determine which technique is more reliable in diagnosing urethral stricture disease.

Who is the study for?
This trial is for men over 18 who may have a urethral stricture and can follow study procedures. They must be able to give written consent. Men with untreated urinary infections, other conditions that could affect the study, inability to consent, or those with a urethral fistula are excluded.Check my eligibility
What is being tested?
The trial compares two methods of diagnosing urethral strictures: Pulsed Fluoroscopy Retrograde Urethrogram versus Traditional Retrograde Urethrogram. Participants will be randomly assigned to one of these diagnostic tests in equal numbers.See study design
What are the potential side effects?
Potential side effects include complications during the procedure such as discomfort or pain from the insertion of medical instruments into the urethra and exposure to radiation used in imaging techniques.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~intra-procedure (during the urethroplasty)
This trial's timeline: 3 weeks for screening, Varies for treatment, and intra-procedure (during the urethroplasty) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
diagnostic accuracy of pulsed fluoroscopy retrograde urethrogram
diagnostic accuracy of pulsed traditional retrograde urethrogram
Secondary outcome measures
Intraprocedural adverse events

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Pulsed Fluoroscopy Retrograde UrethrogramExperimental Treatment1 Intervention
Group II: Traditional Retrograde UrethrogramActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Northern Ontario School of MedicineLead Sponsor
10 Previous Clinical Trials
876 Total Patients Enrolled

Media Library

Retrograde Urethrogram (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05519566 — N/A
Urethral Stricture Research Study Groups: Pulsed Fluoroscopy Retrograde Urethrogram, Traditional Retrograde Urethrogram
Urethral Stricture Clinical Trial 2023: Retrograde Urethrogram Highlights & Side Effects. Trial Name: NCT05519566 — N/A
Retrograde Urethrogram (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05519566 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit of participants enrolled in this clinical investigation?

"Affirmative. The information available on clinicaltrials.gov confirms that this investigation, which was initially posted in September 1st 2022 is actively looking for participants. A total of 46 individuals must be recruited from one medical centre."

Answered by AI

Is this research currently enrolling participants?

"Correct. The clinicaltrials.gov platform displays that this medical study, which was initially announced on September 1st 2022, is actively seeking applicants. A total of 46 patients need to be enrolled from one site."

Answered by AI
~18 spots leftby Apr 2025